Cyclin D1 represses peroxisome proliferator-activated receptor alpha and inhibits fatty acid oxidation
Sushama Kamarajugadda(Minneapolis VA Health Care System), Jeffrey H. Albrecht(National Institute on Aging)
Cited by 29
Related Papers
Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial
|The Lancet. Gastroenterology & hepatology|2017|249
Akt-mediated Liver Growth Promotes Induction of Cyclin E through a Novel Translational Mechanism and a p21-mediated Cell Cycle Arrest
|Journal of Biological Chemistry|2007|56
Cyclin D1 extensively reprograms metabolism to support biosynthetic pathways in hepatocytes
|Journal of Biological Chemistry|2023|7